首页> 外文OA文献 >AB0590 A SINGLE CENTER RETROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY BETWEEN LOW-DOSE VERSUS HIGH-DOSE RITUXIMAB AS REMISSION INDUCTION THERAPY IN JAPANESE PATIENTS WITH ANCA-ASSOCIATED VASCULITIS

【2h】

AB0590 A SINGLE CENTER RETROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY BETWEEN LOW-DOSE VERSUS HIGH-DOSE RITUXIMAB AS REMISSION INDUCTION THERAPY IN JAPANESE PATIENTS WITH ANCA-ASSOCIATED VASCULITIS

机译：AB0590低剂量与高剂量Rituximab之间的疗效和安全性的单一中心回顾性分析，作为日本患者的缓解诱导治疗患者的ANCA相关血管炎

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kei Hirose; Manami Hirata; Yuriko Yamamura; Akiko Ueno; Masahiro Yamamura;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Correction: Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trial,Low-dose glucocorticoids [J] . BMJ Open . 2018,第1期

机译：校正：小剂量糖皮质激素加利妥昔单抗与高剂量糖皮质激素加利妥昔单抗在ANCA相关性血管炎（LoVAS）中诱导缓解：一项多中心，开放标签，随机对照试验的方案，低剂量糖皮质激素
2. Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trial,Correction: Low-dose glucocorticoids [J] . Yuko Kaneko, Kazuhiro Kurasawa, Takao Sugiyama, BMJ Open . 2017,第12期

机译：小剂量糖皮质激素加利妥昔单抗与高剂量糖皮质激素加利妥昔单抗在ANCA相关性血管炎（LoVAS）中诱导缓解的研究：一项多中心，开放标签，随机对照试验的方案，更正：低剂量糖皮质激素
3. Single-dose rituximab for remission induction and maintenance therapy in ANCA-associated vasculitis: a retrospective analysis of 17 patients [J] . Moog P., Probst M., Kuechle C., Scandinavian journal of rheumatology . 2014,第6期

机译：单剂量利妥昔单抗用于ANCA相关血管炎的缓解诱导和维持治疗：17例患者的回顾性分析
4. A SINGLE-CENTER EXPERIENCE USING CHEMOTHERAPY WITH MELPHALAN-DEXAMETHASONE (M-DEX) IN PATIENTS WITH AL AMYLOIDOSIS AND ADVANCED ORGAN INVOLVEMENT NOT ELIGIBLE FOR HIGH-DOSE MELPHALAN THERAPY (HDM) [C] . U. Hegenbart, T. Bochtler, J.B. Dengler, International Symposium on Amyloidosis . 2008

机译：使用化学疗法的单中心经验与Melphalan-Dexamethasone（M-DEX）的Al淀粉样蛋白病和先进器官参与没有资格获得高剂量Melphalan治疗（HDM）
5. Addition of leukotriene receptor antagonists versus long acting beta agonists to inhaled corticosteroid therapy for asthma treatment in older adults: A retrospective data analysis of effectiveness, safety and cost. [D] . Altawalbeh, Shoroq Mahmoud. 2015

机译：在吸入性糖皮质激素治疗中，将白三烯受体拮抗剂与长效β激动剂相比，用于老年人的哮喘治疗：有效性，安全性和成本的回顾性数据分析。
6. Correction: Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre open-label randomised controlled trial [O] . 2018

机译：校正：小剂量糖皮质激素加利妥昔单抗与大剂量糖皮质激素加利妥昔单抗在ANCA相关性血管炎（LoVAS）中诱导缓解：一项多中心开放标签随机对照试验的方案
7. AB0493 COMPARISON OF EFFICACY AND SAFETY BETWEEN RITUXIMAB AND CYCLOPHOSPHAMIDE IN REMISSION INDUCTION THERAPY FOR JAPANESE ANCA-ASSOCIATED VASCULITIS(AAV) PATIENTS; A SINGLE CENTER RETROSPECTIVE ANALYSIS [O] . M. Kato, H. Shimada, S. Nakashima, 2020

机译：AB0493日本ANCA相关血管炎（AAV）患者中拉妥昔单抗与环磷酰胺之间的疗效和安全性比较;单一中心回顾性分析

AB0590 A SINGLE CENTER RETROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY BETWEEN LOW-DOSE VERSUS HIGH-DOSE RITUXIMAB AS REMISSION INDUCTION THERAPY IN JAPANESE PATIENTS WITH ANCA-ASSOCIATED VASCULITIS

著录项

引文网络

相似文献

相关主题

期刊订阅